Concepedia

Anagha Nadkarni

AN

Statistics

Publications

26

Citations

1.2K

H-Index

18

Active since

2004

Affiliations

Bristol-Myers Squibb (United States)(Current)

Pfizer (United States)

STATinMED (United States)

University of Michigan

Ochsner Medical Center

Anagha Nadkarni is an author at Bristol-Myers Squibb (United States) specializing in clinical pharmacology, medicine, and atrial fibrillation.

Publications per year

2004–2020

26

Publications

26

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients

Gregory Y.H. Lip, Allison Keshishian, Xiaoyan Li et al. · Stroke · 2018 · 318 citations · Full text

, , +17

Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice

Xiaoyan Li, Steve Deitelzweig, Allison Keshishian et al. · Thrombosis and Haemostasis · 2017 · 161 citations · Full text

, , +15

Evaluating medication-related services in a hospital setting using the disconfirmation of expectations model of satisfaction

Suzan N. Kucukarslan, Anagha Nadkarni · Research in Social and Administrative Pharmacy · 2008 · 68 citations

, , +13

Should I stay or should I go? The influence of individual and organizational factors on pharmacists’ future work plans

Caroline A. Gaither, Anagha Nadkarni, David A. Mott et al. · Journal of the American Pharmacists Association · 2007 · 66 citations

, , +13

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients

Steven Deitelzweig, Allison Keshishian, Xiaoyan Li et al. · Journal of the American Geriatrics Society · 2019 · 54 citations · Full text

, , +17

1–5 of 26